White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial-Reference-Cited by-同舟云学术

White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial

Published:2021-05-18 Issue:1 Volume:33 Page:45-51
ISSN:0954-6928
Container-title:Coronary Artery Disease
language:en
Short-container-title:

Author:

Claessen Bimmer E.,Ben-Yehuda Ori,Mehran Roxana,Sorrentino Sabato,Guedeney Paul,Chen Shmuel,Dressler Ovidiu,Kini Annapoorna S.,Sharma Samin K.,Mansour Samer,Noiseux Nicolas,Li Ditian,Kappetein Arie Pieter,Sabik Joseph F.,Serruys Patrick W.,Stone Gregg W.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference26 articles.

1. Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease.;Bittl;Circulation,2013

2. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the coronary artery bypass graft surgery trialists collaboration.;Yusuf;Lancet,1994

3. Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial.;Palmerini;Circulation,2011

4. Association among leukocyte count, mortality, and bleeding in patients with non-ST-segment elevation acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] trial).;Palmerini;Am J Cardiol,2013

5. Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial).;Palmerini;Am J Cardiol,2013